WET AGE-RELATED MACULAR DEGENERATION
DIABETIC MACULAR EDEMA
DIABETIC RETINOPATHY
NON-INFECTIOUS UVEITIS
DRY AGE-RELATED MACULAR DEGENERATION
RETINAL VEIN OCCLUSION
NON-ARTERITIC CENTRAL RETINAL ARTERY OCCLUSION
2104 Atmosphere Study and RGX-314-3101 Ascent Study– A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD
BP41670 Burgundy Study – A Two-Part, Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7250284 following Intravitreal Administration of Unmasked Multiple Ascending Doses and Sustained Delivery from the Port Delivery System in Patients with Neovascular Age-Related Macular Degeneration
OTX-TKI-2023-AMD-301 SOL Study – A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study
to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-
Related Macular Degeneration
4951-002 Study – A Phase 2, Multicenter, Randomized, Double-Masked, Parallel-Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients with Neovascular Age-Related Macular Degeneration
ML43000 Belvedere Study – A Phase IV, Open-Label Study of the Response to Treatment after Transition to the Port Delivery System with Ranibizumab (SUSVIMO) in Patients with Neovascular Age-Related Macular Degeneration previously treated with intravitreal agents other than Ranibizumab
OTX-TKI-2023-AMD-303 SOL R Study – A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration
VGFTe-HD-OD-2444 Elara Study – A Phase 3B Single Arm Study of Aflibercept 8mg in Participants with Neovascular AMD or Diabetic Macular Edema
4951-003 Study – A Phase 2, Multicenter, Randomized, Double-Masked, Parallel-Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients with Diabetic Macular Edema
VGFTe-HD-OD-2444 Elara Study – A Phase 3B Single Arm Study of Aflibercept 8mg in Participants with Neovascular AMD or Diabetic Macular Edema
No studies enrolling now
PVT-2201-303 Clarity Study – A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate, Posterior, and Panuveitis
81201887NAP0001 Janssen Study – A Prospective Non-interventional Study to Assess Novel Functional Endpoints in Geographic Atrophy and Normal-sighted Participants
ANX007-GA-02 Archer 2 Study – A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients with Geographic Atrophy (GA)
SPIAM-301 ReNEW Study – A Phase 3, Randomized, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects who have Dry Age-Related Macular Degeneration
No studies enrolling now
KDK-1101-02 GION Study – A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the efficacy and safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion